Literature DB >> 29203259

Multicentre study of patient-reported and clinical outcomes following immediate and delayed Autologous Breast Reconstruction And Radiotherapy (ABRAR study).

Kathryn H Steele1, R Douglas Macmillan2, Graham R Ball3, Malin Akerlund2, Stephen J McCulley4.   

Abstract

BACKGROUND: Timing of autologous breast reconstruction in patients requiring adjuvant radiotherapy remains contentious. The primary objective of this study was to assess clinical and patient reported outcomes in immediate reconstruction with radiotherapy compared to delayed reconstruction after radiotherapy, the two relevant clinical pathways for patients who need radiotherapy.
METHODS: This retrospective UK multi-centre study grouped patients into three categories: immediate reconstruction with post-operative radiotherapy (IBR); delayed reconstruction after radiotherapy (DBR); control group of immediate reconstruction without radiotherapy (noRT). Data collection utilised clinician questionnaire, patient questionnaire (BreastQ) and medical examination. Examination assessed fat necrosis, texture, symmetry and overall result.
RESULTS: 412 patients were recruited (IBR 104; DBR 119; noRT 189) with median follow-up time of 57 months. Post-operative complications were higher in IBR &amp; noRT (p <0.001). Total number of operations for completion of reconstruction was similar in all groups. Completion of reconstruction after mastectomy was three years longer in DBR versus IBR. BreastQ domain scores were lower in IBR versus DBR and noRT (p <0.01) but all scores were within acceptable range (satisfaction with outcome: IBR 71; DBR 85; noRT 81). Examination scores were similar for IBR and DBR but lower than noRT (p <0.01). Correlation between BreastQ and examination scores was poor.
CONCLUSIONS: Acceptable results are observed with either IBR or DBR, with high rates of patient and clinician satisfaction, low rates of complications, and a similar number of operations to complete reconstruction in all groups suggesting all options should be considered for patients.
Copyright © 2017 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Autologous; Breast reconstruction; Delayed reconstruction; Immediate reconstruction; Outcome; Radiotherapy

Mesh:

Year:  2017        PMID: 29203259     DOI: 10.1016/j.bjps.2017.10.030

Source DB:  PubMed          Journal:  J Plast Reconstr Aesthet Surg        ISSN: 1748-6815            Impact factor:   2.740


  5 in total

1.  Principles of patient-centred care and barriers to their implementation: a case study of breast reconstruction in Australia.

Authors:  Kathy Flitcroft; Meagan Brennan; Andrew Spillane
Journal:  Support Care Cancer       Date:  2019-08-02       Impact factor: 3.603

2.  Implant-based immediate breast reconstruction: failure rate when radiating the tissue expander or the permanent implant-a meta-analysis.

Authors:  Víctor Fuertes; Mónica Francés; José M Casarrubios; Javier Fernández-Palacios; Jesús María González; Juan Francisco Loro-Ferrer
Journal:  Gland Surg       Date:  2020-04

3.  Objective assessment of flap volume changes and aesthetic results after adjuvant radiation therapy in patients undergoing immediate autologous breast reconstruction.

Authors:  Yujin Myung; Yousung Son; Tae-Hyun Nam; Eunyoung Kang; Eun-Kyu Kim; In Ah Kim; Keun-Yong Eom; Chan Yeong Heo; Jae Hoon Jeong
Journal:  PLoS One       Date:  2018-05-21       Impact factor: 3.240

4.  Breast Reconstruction-Prospective Follow up on Breast Cancer Patients' Health-Related Quality of Life.

Authors:  Mervi Rautalin; Tiina Jahkola; Risto P Roine
Journal:  World J Surg       Date:  2022-01-09       Impact factor: 3.352

5.  Long-term outcomes of immediate autologous breast reconstruction after definite adjuvant therapy in intermediate and locally advanced breast cancer.

Authors:  Won Sup Yoon; Chai Hong Rim; Dae Sik Yang; Jung Ae Lee; Gil Soo Son; Young Woo Chang; Sang Uk Woo; Deok-Woo Kim; Eun-Sang Dhong
Journal:  Ann Transl Med       Date:  2019-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.